Ownership Submission
FORM 5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Form 3 Holdings Reported
Form 4 Transactions Reported
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0362
Expires: January 31, 2005
Estimated average burden hours per response... 1.0

1. Name and Address of Reporting Person *
LUCI DAVID P
 2. Issuer Name and Ticker or Trading Symbol
BIOENVISION INC [BIVN] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
CFO, General Counsel
(Last)
(First)
(Middle)

C/O BIOENVISION, INC., 345 PARK AVE., 41ST. FLOOR		 3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
06/30/2005
(Street)


NEW YORK,, NY 10154		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Reporting
(check applicable line)

_X_ Form Filed by One Reporting Person
___ Form Filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Amount (A) or (D) Price
Common Stock, par value $.001 per share 11/24/2004   M4 33,946 A $ 0.735 369,054 D  
Common Stock, par value $.001 per share 12/30/2004   S4 10,000 A $ 9 (1) 369,054 D  
Common Stock, par value $.001 per share 01/03/2005   S4 23,946 A $ 8.81 (1) 369,054 D  
Common Stock, par value $.001 per share 01/07/2005   M4 246,054 A $ 0.735 369,054 D  
Common Stock, par value $.001 per share 04/22/2005   M4 110,000 A $ 0.735 369,054 D  
Common Stock, par value $.001 per share 03/23/2005   P4 5,000 A $ 5.6 369,054 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 2270 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned at End of Issuer's Fiscal Year
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
(A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to purchase Common Stock $ 0.735 11/24/2004   M4   33,946 03/31/2003 03/13/2013 Common Stock
33,946
$ 0.735 455,000
D
 
Option to purchase Common Stock $ 0.735 01/07/2005   M4   246,054 03/31/2004 03/13/2013 Common Stock
246,054
$ 0.735 455,000
D
 
Option to purchase Common Stock $ 0.735 11/24/2004   M4   110,000 03/31/2004 03/13/2013 Common Stock
110,000
$ 0.735 455,000
D
 
Option to purchase Common Stock $ 8.17 01/06/2005   A4 40,000   01/06/2005 01/06/2015 Common Stock
40,000
$ 8.17 455,000
D
 
Option to purchase Common Stock $ 8.17 01/06/2005   A4 40,000   01/06/2006 01/06/2015 Common Stock
40,000
$ 8.17 455,000
D
 
Option to purchase Common Stock $ 8.17 01/06/2005   A4 40,000   01/06/2007 01/06/2015 Common Stock
40,000
$ 8.17 455,000
D
 
Option to purchase Common Stock $ 8.17 01/06/2005   A4 40,000   01/06/2008 01/06/2015 Common Stock
40,000
$ 8.17 455,000
D
 

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
LUCI DAVID P
C/O BIOENVISION, INC.
345 PARK AVE., 41ST. FLOOR
NEW YORK,, NY 10154		       CFO, General Counsel  

Signatures

/S/ David P. Luci 08/12/2005
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) This is the market price at which these shares were sold.

Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.